Posted by Michael Wonder on 15 Dec 2015
Evolocumab: no evidence of additional clinical benefits says IQWiG
15 December 2015 - The dossier did not contain appropriate data for patients with hypercholesterolaemia nor for mixed dyslipidaemia.
For more details, go to: https://www.iqwig.de/de/presse/pressemitteilungen/pressemitteilungen/evolocumab-kein-anhaltspunkt-fur-zusatznutzen.7101.html?&et_cid=4&et_lid=%25208
